Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH
Clinical trial NCT07102511 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07102511
- Sponsor
- LIB Therapeutics LLC
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-20
- Primary completion
- 2028-07-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.